Related Experiment Video
Updated: Jun 4, 2026
06:22
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: April 7, 2021
[Acute lung failure]
Ulrike Olgemöller1, Christian Becker1, Lars-Olav Harnisch2
1Universitätsmedizin Göttingen, Klinik für Kardiologie und Pneumologie, Deutschland, Göttingen.
Pneumologie (Stuttgart, Germany)
|June 2, 2026
Summary
Acute respiratory distress syndrome (ARDS) management is evolving with new lung-protective ventilation strategies and rescue therapies like veno-venous extracorporeal membrane oxygenation (VV-ECMO). These advancements aim to reduce mechanical stress and improve patient outcomes in critical care.
Area of Science:
- Critical care medicine
- Pulmonology
- Intensive care
Background:
- Acute respiratory distress syndrome (ARDS) presents significant heterogeneity and a high mortality rate (35-45%).
- Current ARDS management requires continuous evolution to address complex clinical challenges.
Purpose of the Study:
- To provide a comprehensive overview of ARDS fundamentals, diagnostics, and modern therapeutic strategies.
- To highlight the beneficial implementation of new insights in daily clinical practice.
Main Methods:
- Review of current literature on ARDS epidemiology, pathophysiology, and management.
- Discussion of advanced monitoring and ventilation techniques.
- Integration of novel therapeutic options and guidelines.
Main Results:
- Evolving ARDS management incorporates driving pressure and mechanical power for precise control.
- Transpulmonary pressure measurement and automated systems enhance individualized lung-protective ventilation.
- Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is a key rescue therapy, supporting ultra-protective ventilation and "lung rest".
Conclusions:
- Contemporary ARDS care benefits from advanced parameters and technologies for optimized patient management.
- New guidelines and rescue therapies like VV-ECMO offer promising avenues for improving ARDS outcomes.
- Integrating innovative monitoring and ultra-protective ventilation strategies is crucial for effective ARDS treatment.
Related Concept Videos
01:21Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:23Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
01:26Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.